Cargando…

PB2596: OPTIMIZING PLATELET TRANSFUSION FOR CLINICAL PRACTICE. DO PLATELETS AGE MATTER FOR THERAPEUTIC PLATELETS TRANSFUSION?

Detalles Bibliográficos
Autores principales:	Attallah, Samy, Alsharif, Mohammed, Alwali, Barra, Alzaharany, Foad, Alzaharany, Tahani, Bukhari, Zainah, Salami, Ahmed, Alanazy, Wafa, Sami, Hawazen, Mokhles, Samah, Gusti, Amany, Alhazmi, Iman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429764/ http://dx.doi.org/10.1097/01.HS9.0000977076.25234.7f

Ejemplares similares

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.
por: Lee, M., et al.
Publicado: (1988)

Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
por: Zhang, Jing-Cheng, et al.
Publicado: (2023)

Neonatal thrombocytopenia and platelets transfusion
por: Gupta, Anil K., et al.
Publicado: (2012)

Current concepts in platelet transfusion
por: Mohanty, Dipika
Publicado: (2009)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Platelets: Production, Function, Transfusion, and Storage
por: Marchesi, Sally L.
Publicado: (1975)

Thrombocytopenia in leptospirosis and role of platelet transfusion
por: Sharma, Jayashree, et al.
Publicado: (2007)

The Non-Hemostatic Aspects of Transfused Platelets
por: Sut, Caroline, et al.
Publicado: (2018)

Platelet Transfusion: And Update on Challenges and Outcomes
por: Solves Alcaina, Pilar
Publicado: (2020)

Evaluation and management of platelet transfusion refractoriness
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Platelet transfusion for cancer secondary thrombocytopenia: Platelet and cancer cell interaction
por: Wang, Juan, et al.
Publicado: (2021)

Transfusion‐induced platelet antibodies and regulatory T cells in multiply transfused patients
por: Song, Tiejun, et al.
Publicado: (2021)

Rapid decreasing of transfused platelet in a cancerous patient: Anti-platelet antibody
por: Joob, Beuy, et al.
Publicado: (2012)

The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
por: Aoui, Chaker, et al.
Publicado: (2014)

Consensus conference on platelet transfusion: final statement.
Publicado: (1998)

Platelet transfusions: trigger, dose, benefits, and risks
por: Blumberg, Neil, et al.
Publicado: (2010)

Platelet Transfusion – The New Immunology of an Old Therapy
por: Stolla, Moritz, et al.
Publicado: (2015)

Toward the Relevance of Platelet Subpopulations for Transfusion Medicine
por: Handtke, Stefan, et al.
Publicado: (2018)

Routine Screening Method for Microparticles in Platelet Transfusions
por: Millar, Daniel, et al.
Publicado: (2018)

Bacterial contamination of platelets for transfusion: strategies for prevention
por: Levy, Jerrold H., et al.
Publicado: (2018)

New Emerging Developments of Platelets in Transfusion Medicine
por: Stolla, Moritz, et al.
Publicado: (2020)

Transfusion Triggers for Platelets and Other Blood Products
por: Karanth, Sunil
Publicado: (2019)

Impact of platelet transfusion on outcomes in trauma patients
por: Hamada, S. R., et al.
Publicado: (2022)

Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions
por: Bianchi, Juliana Vieira dos Santos, et al.
Publicado: (2012)

Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion
por: Sonego, Giona, et al.
Publicado: (2017)

Evaluation of the Association of Platelet Count, Mean Platelet Volume, and Platelet Transfusion With Intraventricular Hemorrhage and Death Among Preterm Infants
por: Chen, Chong, et al.
Publicado: (2022)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

Risk-Reduction Strategies for Platelet Transfusion in the United States
por: Vamvakas, Eleftherios C.
Publicado: (2011)

Neonatal thrombocytopenia—causes and outcomes following platelet transfusions
por: Resch, Elisabeth, et al.
Publicado: (2018)

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion
por: Belizaire, Roger, et al.
Publicado: (2020)

Non–evidence-based platelet transfusions for protocol eligibility
por: Vossoughi, Sarah, et al.
Publicado: (2020)

Overview of Plasma and Platelet Transfusions in Critically Ill Children
por: Kahn, Stacie, et al.
Publicado: (2020)

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

Comments on: Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions
por: de Paula, Erich Vinicius
Publicado: (2012)

Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion
por: Saris, Anno, et al.
Publicado: (2018)

Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion
por: Garraud, Olivier, et al.
Publicado: (2019)

Neonatal Thrombocytopenia and the Role of the Platelet Mass Index in Platelet Transfusion in the Neonatal Intensive Care Unit
por: Kasap, Tuba, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebllh9485lj9us79k3adinchir